Karyopharm Therapeutics(DE:25K0)
€0.020.00 (0.00%)
DE:25K0
Karyopharm Therapeutics earnings date
€0.02
At close:0.00 (0.00%)
Karyopharm Therapeutics (25K0) Q3 2018 Earnings Report
1 Followers
DE:25K0 Q3 2018 EPS Results
- Actual EPS
- -EUR 0.71
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.58
DE:25K0 Q3 2018 Revenue Results
- Actual Revenue
- EUR 214.34K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/08/2018
- Time
- TBA
- Conference Call
- Thursday, November 8, 2018
DE:25K0 Upcoming Earnings
Karyopharm Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:25K0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | ―- | -5.12 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.30- | -3.43 | ― | |
| Aug 13, 2026 | 2026 (Q2) | -1.23-2.08 | -3.87 | 46.30% (+1.79) | |
| May 14, 2026 | 2026 (Q1) | -1.27-1.11 | -2.48 | 55.23% (+1.37) | |
| Feb 12, 2026 | 2025 (Q4) | -1.79-5.12 | -3.23 | -58.61% (-1.89) | |
| Nov 03, 2025 | 2025 (Q3) | -3.11-3.43 | -3.5 | 2.05% (+0.07) | |
| Aug 11, 2025 | 2025 (Q2) | -3.66-3.87 | -2.69 | -44.00% (-1.18) | |
| May 12, 2025 | 2025 (Q1) | -3.96-2.48 | -4.3 | 42.29% (+1.82) | |
| Feb 19, 2025 | 2024 (Q4) | -3.52-3.23 | -4.84 | 33.33% (+1.61) | |
| Nov 05, 2024 | 2024 (Q3) | -3.54-3.50 | -4.04 | 13.33% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

